THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Health care reform still key topic for Daschle

By David D. Kirkpatrick
New York Times / August 23, 2009

E-mail this article

Invalid email address
Invalid email address

Sending your article

Your article has been sent.

  • Email|
  • Print|
  • Reprints|
  • |
Text size +

WASHINGTON - Six months have passed since the morning when Tom Daschle, the former Senate Democratic leader, under fire for not paying certain taxes, called President Obama in his study off the Oval Office to withdraw his nomination as health secretary.

But these days it often seems as if Daschle never left the picture. With unrivaled ties on both ends of Pennsylvania Avenue, Daschle still talks constantly with top White House advisers, many of whom previously worked for him.

He still speaks frequently to the president, who met with him as recently as Friday morning in the Oval Office.

And he also remains a highly paid policy adviser to hospital, drug, pharmaceutical and other health care industry clients of Alston & Bird, the law and lobbying firm.

Now the White House and Senate Democratic leaders appear to be moving toward a blueprint for overhauling the health system - centered on nonprofit insurance cooperatives - that Daschle began promoting two months ago as a politically feasible alternative to a more muscular government-run insurance plan.

It is an idea that also happens to dovetail with the interests of many Alston & Bird clients, like the insurance giant UnitedHealth and the Tennessee Hospital Association.

And it is drawing angry cries of accommodation from more liberal House Democrats bent on including a public insurance plan.

Friends and associates of Daschle’s say the interests of Alston & Bird’s clients have no influence on his views.

They say he sees no conflict in advising private clients on the one hand, and advising the White House on the other, because he offers the same assessment to everyone: Though he has often said that he favors a government-run insurance option, the Senate will not pass it.

“The message I deliver to labor unions and business leaders is the same one I share with doctors, hospitals and insurance companies,’’ Daschle wrote in a brief e-mailed statement. “I do not tailor my views to any specific group or client.’’

Critics, though, say his ex officio role gives Alston & Bird’s health care clients privileged insights into the policy process. They say Daschle’s multiple advisory roles illustrate the kind of coziness with the lobbying world that Obama vowed to end. If he had been confirmed as health secretary, Daschle would have been subject to strict transparency and ethics rules.

Daschle’s position, some liberals say, raises at least an appearance of a conflict of interest. “I hope the president can make a decision based on what the country wants, not what a handful of Daschle’s clients want,’’ said Representative Lynn Woolsey of California, a leader of the progressive caucus.

Daschle both recommends and predicts an incremental approach. “We are not going to see this happen overnight. It can’t. It is too big a shift in the economy,’’ he told a biotechnology trade group in May. If the legislation can begin to “ramp up’’ coverage for all, health information technology and some cost controls, “we will have succeeded,’’ Daschle said.